The effect of daily fortified yogurt consumption on weight loss in adults with metabolic syndrome: A 10-week randomized controlled trial

Nutr Metab Cardiovasc Dis. 2018 Jun;28(6):565-574. doi: 10.1016/j.numecd.2018.03.001. Epub 2018 Mar 10.

Abstract

Background and aims: Obesity is a complex and multifaceted condition. Thus, functional foods need investigation as novel adjunct treatments for obesity. The objective was to determine the effects of daily consumption of a fortified yogurt (FY) on weight loss in overweight and obese patients with metabolic syndrome on a caloric-restricted diet.

Methods and results: This was a randomized, double-blind, 10-week study. Participants were randomly allocated to two groups receiving either two servings (2 × 250 g)/day of FY with whey protein, calcium, vitamin D, prebiotic fibre and probiotic cultures (n = 44) or a low-fat plain yogurt (PY) (n = 43). All participants were put on a calorie-restricted diet throughout the 10-week study. Body composition and biochemical indices were assessed before and after the intervention. Body mass decreased by 4.3 ± 1.9 kg and 5.1 ± 3.0 kg in the PY and FY groups, respectively, following the 10-week intervention. Compared to PY, consumption of FY resulted in a significant reduction in body fat mass (FM) (p = 0.023), body fat percentage (p = 0.028), waist circumference (p = 0.002), homoeostasis model of assessment-insulin resistance (HOMA-IR) (p = 0.025), triglyceride concentration (p = 0.003), and a significant increase in total 25-hydroxyvitamin D (25(OH)D) concentration (p < 0.001), high density lipoprotein-cholesterol (HDL-C) (p = 0.009) and quantitative insulin sensitivity check index (QUICKI) (0.022). Participants consuming the FY lost less fat-free mass (FFM) compared to the PY group (Δ = -0.9 ± 3.5 kg vs. Δ = -2.0 ± 2.7 kg; p = 0.025).

Conclusions: Consuming FY for 10-weeks improved body composition and metabolic parameters, while on a caloric-restricted diet. Further research is needed to elucidate whether FY can be used as a preventative strategy for metabolic syndrome in obese persons.

Trial registration: www.irct.ir (IRCT2017050633836N1).

Keywords: Metabolic syndrome; Obesity; Probiotic; Yogurt.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiposity
  • Adult
  • Aged
  • Calcium / administration & dosage
  • Caloric Restriction*
  • Double-Blind Method
  • Female
  • Food, Fortified* / microbiology
  • Humans
  • Iran
  • Male
  • Metabolic Syndrome / diagnosis
  • Metabolic Syndrome / diet therapy*
  • Metabolic Syndrome / microbiology
  • Metabolic Syndrome / physiopathology
  • Middle Aged
  • Obesity / diagnosis
  • Obesity / diet therapy*
  • Obesity / microbiology
  • Obesity / physiopathology
  • Portion Size
  • Prebiotics / administration & dosage
  • Probiotics / administration & dosage
  • Recommended Dietary Allowances
  • Time Factors
  • Treatment Outcome
  • Vitamin D / administration & dosage
  • Weight Loss*
  • Whey Proteins / administration & dosage
  • Yogurt* / microbiology
  • Young Adult

Substances

  • Prebiotics
  • Whey Proteins
  • Vitamin D
  • Calcium